Clinical Trial: Evaluation of the efficacy and safety of emtricitabine on improvement of 28-day survival in patients with heat stroke: a single-arm, multicenter, exploratory clinical study (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the efficacy and safety of emtricitabine on improvement of 28-day survival in patients with heat stroke: a single-arm, multicenter, exploratory clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130434

Registration Time: 2026/08/20

Type: Interventional study

Primary Sponsor: The Third Affiliated Hospital of Guangzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334606

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Evaluation of the efficacy and safety of emtricitabine on improvement of 28-day survival in patients with heat stroke: a single-arm, multicenter, exploratory clinical study (China)